Sort   by:  
 Page size 
UnknownResearch on potential biomarkers in hereditary hemorrhagic telangiectasia.
Not available
S-EPMC4379940 | biostudies-literature
UnknownBlockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma.
Not available
S-EPMC8835934 | biostudies-literature
UnknownPropranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies.
Not available
S-EPMC9369479 | biostudies-literature
UnknownThe Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases.
Not available
S-EPMC9025921 | biostudies-literature
UnknownMutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
Not available
S-EPMC5324315 | biostudies-literature
UnknownThe Endothelial Landscape and Its Role in Von Hippel-Lindau Disease.
Not available
S-EPMC8465092 | biostudies-literature
UnknownReview of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding.
Not available
S-EPMC7356836 | biostudies-literature
UnknownRepurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Not available
S-EPMC5492903 | biostudies-literature
UnknownMutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth.
Not available
S-EPMC10739370 | biostudies-literature
UnknownCopy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1.
Not available
S-EPMC4222255 | biostudies-literature
Sort   by:  
 Page size